Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile

• Gregory L. Peterfreund,

  Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Lee E. Vandivier,

  Affiliation Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Rohini Sinha,

  Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Andre J. Marozsan,

  Current address: Alexion Pharmaceuticals, Cheshire, Connecticut, United States of America

  Affiliation Progenics Pharmaceuticals, Tarrytown, New York, United States of America

  ⨯
• William C. Olson,

  Affiliation Progenics Pharmaceuticals, Tarrytown, New York, United States of America

  ⨯
• Jun Zhu,

  Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Frederic D. Bushman

  * E-mail: bushman@mail.med.upenn.edu

  Affiliation Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯